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Abstract 
Purpose: To describe the landscape of medication management within the patient-centered medical homes (PCMH) in the state of 
Minnesota. Methods:  An electronic survey of care coordinators within PCMHs certified with the Department of Health in state of 
Minnesota was conducted.  The survey and follow up were distributed by the Minnesota Department of Health.  At the time the 
survey was distributed, there were 161 certified PCMHs in the state. Results:  The final analysis included 21 respondents.  Size, 
setting, and time as a certified PCMH varied between practices.  PCMHs reported a higher percentage of patients enrolled at lower 
complexity tiers (35.0 percent at tier I and 40.4 percent enrolled at tier II), with PCMHs with clinical pharmacist services reporting 
slightly increased frequency of higher complexity patients. The composition of the care team varied from clinic to clinic, but all clinics 
were multidisciplinary with a mean of 5.8 different provider types listed for each clinic.  Physicians were the most common providers 
of medication management across all settings, and one respondent reported that medication management services are not formally 
provided in his/her clinic.  The presence or absence of a clinical pharmacist did not significantly influence care coordination time 
dedicated to medication-related activities.  Respondents residing in a clinic with clinical pharmacist services reported a high level of 
satisfaction with pharmacist-provided services. Conclusion: The implementation of the PCMH model in many of the participating 
clinics was relatively recent and there remains much to be learned regarding the landscape of comprehensive medication 
management in the PCMH.  The reported distribution of patients in complexity tiers suggests that clinics may use different strategies 
to determine resource allocation.  Although the presence of a clinical pharmacist did not influence care coordination time dedicated, 
care coordinators valued services provided by clinical pharmacists.  
 
 
Introduction 
In 2008, the Minnesota legislature passed a healthcare 
reform package, developing a framework for patient-
centered medical homes (PCMH) in the state.  Clinics may be 
certified with the Minnesota Department of Health (MDH) as 
a “healthcare home,” or PCMH.  According to MDH, currently, 
there are 192 PCMHs certified, serving over two million 
patients across the state.
1
 The PCMH is a model of primary 
care intended to improve health outcomes and quality of life 
for patients with chronic diseases.
2
 
 
Medications represent the most common medical 
intervention for chronic diseases, and their potential for both  
benefit and harm is immense.  Comprehensive medication 
management allows for the optimization of medication  
 
 
 
outcomes and experiences.  Medication management occurs 
regularly, to varying degrees, in the primary care setting.  
With the increasing profile of local and national PCMHs, an 
understanding of how medication management is currently 
delivered will advise successful integration of comprehensive 
medication management services. 
 
Integration of pharmacy services into the PCMH is occurring 
in clinics across the country, 
3,4,5,6,7
 however, little information 
is available regarding current medication management 
practices.  Smith and colleagues draw on previous literature 
about successful models of comprehensive medication 
management in primary care to describe potential roles for 
pharmacists within the PCMH.  Providing comprehensive 
medication management, recommending cost-effective 
therapies, and educating patients are described as key areas 
of pharmacist involvement.
8
 The integration of clinical 
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pharmacists in eight Michigan PCMHs involved a systematic 
process for training pharmacists and standardizing work so 
the clinical process and target patient group at each clinic 
mirrored the others.
3
 Interviews of physicians, clinic staff, 
pharmacists and patients in one study describe an overall 
positive reaction to the integration of a pharmacist within the 
PCMH with participants indicating that the pharmacist 
improved care and was a valuable resource for providers and 
staff.
4
  In their recent article describing the pharmacist role 
on a collaborative team providing care to a homeless 
population, Moczygemba and colleagues acknowledge that 
additional research is needed to clarify and define the roles of 
pharmacists on interprofessional teams and within the 
PCMH.
9
 
 
Minnesota is a somewhat unique environment with regards 
to the provision of Medication Therapy Management (MTM) 
services.  State Medicaid, as well as several private health 
insurers, compensates pharmacists for MTM provision on a 
fee-for-service basis.  In the state of MN there were 241 
pharmacists credentialed with the state Medicaid system to 
receive compensation for clinical pharmacy services at the 
time the survey was distributed.  This payment structure has 
allowed health systems to include clinical pharmacists on the 
healthcare team.  Such integration is often challenging 
outside of Veterans Affairs Healthcare Systems and joint 
academic appointments with a School or College of 
Pharmacy.  
 
Current literature describes individual clinic or health system 
approaches to integrating pharmacists into PCMHs.  To date, 
little work has detailed generalized processes across settings 
to describe a broader picture of the landscape of 
comprehensive medication management within the PCMH.  
In a healthcare environment with limited resources, it is of 
utmost importance to understand efficient processes of care 
leading to optimal clinical outcomes.  To achieve this, a 
thorough appreciation of current practices is needed.  This 
study aims to describe the landscape of comprehensive 
medication management in Minnesota PCMHs.   
 
Methods 
Design and Sample 
This is a descriptive study conducted in the state of 
Minnesota.  Care coordinators in PCMHs certified with the 
MDH were eligible to participate.  Care coordinators were 
targeted for this survey because they are a necessary and 
instrumental component of the PCMH team.  Eligible 
participants were identified by MDH and surveys were 
distributed electronically to PCMH contacts by MDH using 
Qualtrics (Qualtrics Labs Inc., Provo, UT).  A single follow-up 
e-mail was administered by MDH.  At the time the survey was 
distributed, there were 161 certified PCMH in the state.   
 
Survey Instrument 
A 15-item survey was developed to assess the landscape of 
medication management in Minnesota PCMHs (Appendix 1).  
The survey instrument was piloted with three care 
coordinators and was reviewed by MDH.  Survey questions 
did not require an answer to progress through the survey.  
 
All respondents were asked to complete 13 items. Two items 
were asked to be completed only by respondents who were 
part of a PCMH with a pharmacist on the care team.  Of the 
13 items completed by all respondents, seven gathered 
demographic information including full time equivalents 
(FTEs) dedicated to care coordination, PCMH setting 
(urban/rural), number of providers in the PCMH, length of 
time the clinic has been operating as a certified PCMH, 
number of patients enrolled, distribution of patients in 
complexity tiers 
(http://www.health.state.mn.us/healthreform/homes/payme
nt/index.html), and types of providers on the PCMH care 
team.  Four items asked the respondents to estimate the 
percent of time care coordinators dedicated to a variety of 
medication-related activities.  Questions regarding care 
coordination time dedicated to medication-related activities 
were included to determine if any correlation exists between 
pharmacist presence and time spent on medication-related 
activities as well as to identify opportunities for pharmacist 
involvement in the PCMH.  Finally, comprehensive 
medication management was defined and respondents were 
asked to identify the types of providers responsible for 
providing comprehensive medication management in their 
clinic.  PCMH with a pharmacist were identified with a simple 
yes or no question inquiring if the clinic had a pharmacist on 
the PCMH team.  Respondents indicating the presence of a 
pharmacist on the care team were directed to answer two 
additional questions regarding pharmacist visits in the PCMH.  
Respondents were asked to ascertain the mechanism for 
identifying patients to refer to the pharmacist.  Respondents 
were also asked to respond to a series of statements on a 
likert scale regarding their experiences with the pharmacist 
on the PCMH team.  This research was designated IRB not 
required by the Institutional Review Board at the University 
of Minnesota.   
 
Data Analysis 
Descriptive statistics (mean, frequency, percent) calculated 
using Microsoft Office Excel (2010) used for all variables.  Raw 
data was analyzed for outliers that would significantly skew 
descriptive statistics.   
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Questions regarding care coordination time dedicated to 
medication-related activities were asked individually and 
respondents selected a range of percent of time dedicated to 
such activities.  To allow for clear reporting of this data, the 
median of the range was used to calculate the mean time 
dedicated to medication-related activities.  Seven 
respondents’ total time on these four questions exceeded 
100 percent, so these responses were standardized to the 
mean to allow for more representative reporting.   
 
Results 
Responses 
Twenty-eight care coordinators initiated the survey.  Seven 
responses were deemed outliers and removed from the 
analysis.  Four of these responses were removed because the 
clinic reported 50 or more providers in the PCMH, which did 
not reflect the remainder of the clinics reporting 30 or fewer 
providers.  The remaining three responses removed reported 
at least 50 percent of the patients enrolled in the PCMH to be 
tier IV complexity.  These were deemed to be outliers 
because the range in tier IV composition without these 
responses was zero to 20 percent with a mean of 5.4 percent. 
Two respondents did not complete the survey.  The items 
completed by these respondents were included in the 
analysis.  The final analysis included 21 respondents.  
 
Demographics 
Of the 21 responses included in the analysis, 11 were in the 
urban setting and ten in the rural setting.  PCMH reported full 
time equivalents (FTEs) dedicated to care coordination 
ranged from 0.4 to four FTEs with most reporting two FTEs 
dedicated to care coordination. Reported number of 
providers in the PCMH ranged from less than five to 30 
providers with most settings reporting five to 20 providers. 
Respondents most commonly reported being a certified 
PCMH for one to 1.5 years and having 100 to 149 patients 
enrolled (Table 1). PCMH demographic information did not 
vary significantly with respect to setting (urban/rural) or 
presence/absence of a pharmacist except rural settings were 
associated with an increased duration in PCMH at 1.5 to two 
years compared to urban duration at one to 1.5 years (p = 
0.02).  
 
Responses indicated that the majority of patients within the 
PCMH in the state of Minnesota are at tier I and tier II 
complexity.  Subgroup analysis revealed a difference in 
complexity in the presence and absence of a pharmacist with 
slightly greater complexity in PCMH with a pharmacist as 
compared to those without.  A statistically significant 
difference in percent of patients in tier I was observed 
between PCMH with presence and absence of a pharmacist 
(Table 2).  
 
The mean number of health provider types reported on the 
core PCMH team was 5.8 providers.  Full reporting of the 
frequency of different providers on the core PCMH team can 
be found in Table 3.  
 
Medication Management within the PCMH 
Care coordinators reported most commonly spending time on 
adherence and medication-monitoring-related activities. An 
increase in total time spent on medication-related activities 
was observed in PCMH with a clinical pharmacist (Tables 4 
and 5). Nurse practitioners, pharmacists, physicians, physician 
assistants, and registered nurses were all reported as 
providers of medication management services, with 
physicians reported as the most common providers of 
medication management (Table 6).   
 
Pharmacist Services in the PCMH 
Of the 21 responses included in the analysis, 11 reported the 
presence of a pharmacist on the core PCMH team.  Three key 
members of the PCMH team were reported to be involved in 
referring patients for clinical pharmacy services including the 
primary care provider, care coordinator, and pharmacist (with 
10, 10, and 5 reports respectively).  Six responses indicated 
that patients are self-referred for clinical pharmacy services 
within the PCMH.  A respondent from one PCMH reported 
that there is no system in place for referrals to the clinical 
pharmacist.     
 
Respondents were asked to rate their experiences with the 
pharmacist on the PCMH team on several items including 
saving the care coordinator time, a great resource for 
patients, a great resource for the care coordinator, a great 
resource for providers, benefits the patient, benefits the care 
coordinator, benefits the medical staff.  Responses were 
predominantly positively to these statements will all 
responses as “strongly agree” or “agree” on all measures 
except one response of “no opinion” on the pharmacist 
saving the care coordinator time, pharmacist is a great 
resource for patients, and the pharmacist is a great resource 
for providers.   
 
Discussion 
The advent of the PCMH model in the state of Minnesota is 
relatively recent.  In this project, most clinics reported 
providing services as a certified PCMH for between one and 
1.5 years and only one respondent represented a PCMH 
certified for two or more years.  The recent adoption of the 
PCMH model indicates that there is still much to be learned 
regarding practices in the PCMH, including practices for 
medication management.  
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Urban or rural setting was not associated with meaningful 
differences in demographics, with the exception of rural 
clinics reporting entering the PCMH model earlier than urban 
clinics. The significance of the timing of entering the PCMH is 
unclear, however longer duration as a certified PCMH 
suggests that clinics may have more established systems for 
recruiting patients into the PCMH and for management once 
enrolled.  
 
Across settings, the majority of patients were enrolled at 
complexity tiers I and II.  This may be an indicator of clinic 
strategy for enrolling patients to use limited resources to 
provide for the most patients.  It also may be a gauge of the 
medical complexity required for patients to qualify for higher 
tiers.  The presence of a pharmacist on the team was 
associated with patients enrolled at higher complexity, with 
the majority of patients enrolled at tier II and III, rather than I 
and II, which was seen within clinics without a pharmacist.  
Although this was not statistically significant, it suggests a 
difference between clinics with and without a clinical 
pharmacist.  There are several explanations for the difference 
in the distribution of patients across complexity tiers 
between clinics with and without a pharmacist.  One such 
reason is that PCMH with higher tiered patients are recruiting 
team members, such as pharmacists, to help address the 
needs of the patients enrolled.  As stated previously, 
medications represent the most common intervention for 
chronic diseases, and a pharmacist would be uniquely 
positioned to help address the medication-related needs of 
complex patients.  A second explanation simply reverses the 
causality pathway, suggesting that if a pharmacist is on the 
team the PCMH may recruit more complex patients due to 
the resources available to serve this population.  
 
Composition of care team varied from clinic to clinic, but all 
were multidisciplinary in nature.  Most commonly, core 
PCMH teams included primary care physicians, registered 
nurses, nurse practitioners, social workers, pharmacists, and 
physician assistants.  However this study did not evaluate 
how the team worked together.  This study simply evaluated 
who was on the team and what team members are 
responsible for medication management.  
 
Care coordinator time dedicated to medication-related 
activities was gathered to begin describing the medication 
management process within the healthcare home.  
Responses indicate that medication-related activities require 
a substantial amount of time on the part of care coordinators.  
It could be anticipated that the presence of a pharmacist 
would be associated with less time spent by the care 
coordinator on medication-related activities.  However, this 
was not the case. There was a trend toward additional time 
spent by care coordinators on medication-related activities in 
clinics with a pharmacist as compared to those without a 
pharmacist.  There are likely several factors contributing to 
this increase in time, including an increase in more complex 
patients in clinics containing a pharmacist.  It is also possible 
that pharmacists in these clinics raise the awareness of 
medication-related needs of patients, thereby increasing the 
time spent on care coordination activities related to these 
needs.   
 
Survey responses indicate that a variety of provider types are 
delivering comprehensive medication management in the 
PCMH.  According to the Patient Centered Primary Care 
Collaborative (PCPCC), patients at clinical goal or with 
medication regimens of lower complexity may have their 
medications effectively managed by their primary care 
provider.  The PCPCC also states that patients with complex 
medication regimens, adverse effects, or not reaching clinical 
goal will benefit from working directly with a pharmacist, as 
pharmacists have the required knowledge and skills to 
optimize medication regimens.
10
  This assumes that all PCMH 
will have access to a pharmacist.  Recognizing that only about 
half of the clinics participating in our survey have a 
pharmacist on the team, there are significant limitations to 
this assumption.  This may bring to light a barrier to patient 
access to pharmacists practicing in the clinic setting.  It may 
also demonstrate the need to adopt a process of ensuring 
medication management occurs, regardless of provider type, 
and a system for identifying patients requiring referrals to a 
pharmacist.  
 
Survey responses indicated a high level of overall satisfaction 
with pharmacist-provided services.  There are likely several 
factors contributing to this finding including excellent services 
provided and the uncertain role of the pharmacist in the clinic 
setting.  Few people, including healthcare workers, are 
familiar with the scope of the pharmacist.  Many view 
dispensing as a primary function of pharmacist duties.  This 
unfamiliarity may have influenced respondents’ reports of 
satisfaction because services provided broadened the 
perceived scope of practice.   
 
Limitations 
This study has several limitations that must be considered.  
Although the response rate was quite low, this study 
represents the first of its kind in characterizing current 
practices regarding medication management in the PCMH.  
Responses remained anonymous, however the distribution of 
responses characterized as coming from an urban or rural 
setting closely matches that of the certified PCMH across the 
state.
11
  The low response rate was likely the result of only 
one follow-up e-mail as the investigators did not have access 
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to the list of PCMH contacts and MDH was not willing to send 
an additional follow-up e-mail on the investigators’ behalf.  
 
The results pertaining to care coordinator time dedicated to 
medication-related activities revealed a sizable proportion of 
care coordinator time dedicated to medication-related 
activities.  The raw data was standardized because seven 
respondents’ total time spent on medication-related activities 
exceeded 100 percent.  Care coordinators have 
responsibilities beyond medication-related activities so the 
authors decided to standardize these seven responses to the 
mean to allow for interpretation.  This error in data likely 
occurred because the survey items regarding care 
coordination dedicated to medication-related activities 
appeared individually in the survey instrument and 
respondents were not likely able to anticipate that they 
would be asked multiple questions regarding time spent on 
medication-related activities.  Respondents also may not 
have been able to fully distinguish between the activities so 
there may have been some overlap in reported time.   
 
Future directions 
Our study attempted to capture “who” was responsible for 
identifying and referring to the pharmacist for comprehensive 
medication management.  It did not capture “how” this 
occurring.  Understanding effective processes for identifying 
and referring patients is necessary for the development of a 
successful medication management service.  
 
Future attempts to describe care coordinator time spent on 
medication-related activities should allow care coordinators 
to view all items on this topic as well as describe how much, if 
any, is delegated to the pharmacist.   
 
As stated previously, respondents to this survey have spent a 
very limited amount of time in the PCMH.  There remains 
much to learn about best practices in the PCMH and 
maximizing the unique expertise and contributions of all 
members of the healthcare team.   
 
Conclusion 
The implementation of the PCMH model in many of the 
participating clinics was relatively recent and there remains 
much to be learned regarding best practices for 
comprehensive medication management in the PCMH.  The 
reported distribution of patients in complexity tiers suggests 
that clinics may use different patient enrollment and staffing 
strategies to determine optimal resource allocation to 
manage the unique needs of patients enrolled in the PCMH.  
Although the presence of a pharmacist did not influence care 
coordination time dedicated to medication management, 
care coordinators valued services provided by pharmacists. 
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Table 1: PCMH demographics 
 Category Frequency (%) 
FTE dedicated to care 
coordination 
(n=21) 
0.5 FTE 1 (4.7) 
1 FTE 5 (23.8) 
1.5 FTE 0 (0) 
2 FTE 10 (47.6) 
Other
*
  5 (23.8) 
Setting (n=21) Urban 11 (52.4) 
Rural 10 (47.6) 
Number of Medical Providers 
(n=21) 
 
<5 2 (9.5) 
5-10 7 (33.3) 
11-20 7 (33.3) 
21-30 5 (23.8) 
31-40 0 (0) 
41-50 0 (0) 
Time in PCMH (n=21) < 6 months 0 (0) 
6 months to < 1 year 6 (28.6) 
1 year to < 1.5 years 9 (42.9) 
1.5 years to < 2 years 5 (23.8) 
>/= 2 years 1 (4.7) 
Number of patients enrolled 
(n=20) 
< 20 0 (0) 
20-49 3 (15) 
50-99 4 (20) 
100-149 8 (40) 
150-199 2 (10) 
>/= 200 3 (15) 
*“Other” responses for FTE dedicated to care coordination include: 0.4, 0.75, 3, 3.5, 4 
 
 
 
 
Table 2: Distribution of patients in complexity tiers 
 
Tier Cumulative 
Average (range) 
Pharmacist Absent 
Average (range) 
Pharmacist 
Present Average 
(range) 
p-value 
I 35.0 (0-95) 45.4 (0-95) 20.1 (0-60) 0.01 
II 40.4 (3-83) 28.4 (0-45) 50.3 (20-83) 0.05 
III 19.2 (1-40) 14.7 (1-35) 23.3 (7-40) 0.13 
IV 5.4 (0-20) 2.75 (0-10) 6.4 (0-20) 0.19 
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Table 3:  Frequency of health provider type reported on core PCMH team 
 
Provider type Cumulative 
n=21 (%) 
Urban n=11(%) Rural n=10 (%) Pharmacist 
Absent n=8 (%) 
Pharmacist 
Present n= 
11(%) 
Chiropractor 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Licensed 
counselor 
4 (19.0) 1 (9.1) 3 (30.0) 2 (25.0) 2 (18.2) 
Nurse 
practitioner 
14 (66.7) 7 (63.6) 7 (70.0) 7 (87.5) 7 (63.6) 
Occupational 
therapist 
4 (19.0) 1 (9.1) 3 (30.0) 3 (37.5) 2 (18.2) 
Pharmacist 12 (57.1) 7 (63.6) 5 (50.0) 1 (12.5) 9 (81.8) 
Physician 
assistant 
12 (57.1) 6 (54.5) 6 (60.0) 3 (37.5) 8 (72.7) 
Physical 
therapist 
6 (28.6) 2 (18.2) 4 (40.0) 3 (37.5) 2 (18.2) 
Primary care 
physician 
20 (95.2) 10 (90.9) 10 (100) 8 (100) 11 (100) 
Psychiatrist 2 (9.5) 1 (9.1) 1 (10.0) 2 (25.0) 0 (0) 
Psychologist 6 (28.6) 3 (27.3) 3 (30.0) 3 (37.5) 2 (18.2) 
Registered 
nurse 
18 (85.7) 9 (81.8) 9 (90.0) 6 (75.0) 11 (100) 
Social worker 13 (61.9) 9 (81.8) 4 (40.0) 4 (50.0) 8 (72.7) 
Other  10 (47.6) 6 (54.5) 4 (40.0) 7 (87.5) 3 (27.3) 
 
 
 
 
 
Table 4: Percent care coordinator time dedicated to medication-related activities 
 
Medication related 
category 
Cumulative Average  
(n=21) 
Pharmacist Absent 
Average (n=8) 
Pharmacist Present 
Average (n=11) 
Medication 
adherence 
34.5 27.5 39.5 
Medication safety 21.3 11.3 28.6 
Medication 
monitoring 
23.4 23.8 23.2 
Communicating with 
pharmacies 
17.1 13.8 19.1 
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Table 5: Standardized percent care coordinator time dedicated to medication-related activities 
 
Medication related 
category 
Cumulative Average  
(n=21) 
Pharmacist Absent 
Average (n=8) 
Pharmacist Present 
Average (n=11) 
Medication 
adherence 
22.7 19.5 25.1 
Medication safety 11.6 8.4 13.9 
Medication 
monitoring 
14.5 17.9 12.1 
Communicating with 
pharmacies 
10.3 8.7 11.7 
 
 
 
 
 
Table 6: Frequency of provider type offering medication management services in the PCMH 
 
Provider type Cumulative 
n=19 (%) 
Urban n=10 
(%) 
Rural n=9 (%) Pharmacist 
Absent n=8 (%) 
Pharmacist 
Present n= 11 
(%) 
Nurse 
practitioner 
11 (57.9) 5 (50.0) 6 (66.7) 5 (62.5) 7 (63.6) 
Pharmacist 13 (68.4) 7 (70.0) 6 (66.7) 3 (37.5) 10 (90.9) 
Physician 16 (84.2) 8 (80.0) 8 (88.9) 6 (75.0) 10 (90.9) 
Physician 
assistant 
10 (52.6) 5 (50.0) 5 (55.6) 2 (25.0) 8 (72.7) 
Registered 
nurse 
10 (52.6) 4 (40.0) 6 (66.7) 5 (62.5) 6 (54.5) 
Other 2 (10.5) 1 (10.0) 1 (11.1) 1 (12.5) 1* (9.1) 
Not sure 1 (5.3) 1 (10.0) 0 (0) 1 (12.5) 0 (0) 
This type of 
assessment is 
not formally 
provided at 
our clinic 
1 (5.3) 1 (10.0) 0 (0) 1 (12.5) 0 (0) 
*Listed as “MTM”.  MTM can be defined as Medication Therapy Management, which is a pharmacist, provided service.  
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Appendix 1 
 
1/ 7/ 13 Healthcare Home Medicat ion Management Survey
1/ 1https:/ / umpharm.qualt rics.com/ SE/ ?SID= SV_2mGgBqaCIkF29QU&Preview= Survey&BrandID= umpharm
Purpose of the Study:
The data obtained from the surveys will be used to answer the primary research question which is to describe
the landscape of medication management in healthcare homes (HCH) in Minnesota.  The results of this
research will be used in preparation of a manuscript.
 
Survey:
You will complete a survey, which will take approximately 10 minutes. The survey includes questions about
your HCH team and medication management within your HCH. Your participation in this study is complete
upon submission of the survey. The results from all survey participants will be evaluated by the researchers.
Confidentiality:
Your responses will be kept completely confidential. We will NOT know your IP address when you
respond to the Internet survey. 
 
Decision to quit at any time:
Your participation is voluntary; you are free to withdraw your participation from this study at any time. If you do
not want to continue, you can simply leave the survey website. If you do not click on the "submit" button at the
end of the survey, your answers and participation will not be recorded. You also may choose to skip any
questions that you do not wish to answer.
 
How the findings will be used:
The results of the study will be used for scholarly purposes. The results from the study will be presented in
educational settings and at professional conferences, and the results might be published in a professional
journal.
 
Contact information:
If you have concerns or questions about this study, please contact Maggie Wallace (wall0559@umn.edu).
 
By beginning the survey, you acknowledge that you have read this information and agree to participate in this
research, with the knowledge that you are free to withdraw your participation at any time without penalty.
  > >   
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1/ 7/ 13 Healthcare Home Medicat ion Management Survey
1/ 2https:/ / umpharm.qualt rics.com/ SE/ ?SID= SV_2mGgBqaCIkF29QU&Preview= Survey&BrandID= umpharm
0.5  FTE
1  FTE
1.5  FTE
2  FTE
Other
Urban
Rural
<  5
5-­10
11-­20
21-­30
31-­40
41-­50
>50
<  6  months
6  months  to  <  1  year
1  year  to  <  1.5  years
1.5  years  to  <  2  years
>/=  to  2  years
Background
  
My  clinic  has  ________  FTE  dedicated  to  care  coordination.  
My  clinic  is  located  in  a(n)  ____________  community.
Number  of  medical  providers  (physicians,  nurse  practitioners,  and  physician  assistants)  practicing  in  your
clinic.
How  long  has  your  clinic  been  a  certified  Health  Care  Home  (HCH)?
Estimate  the  number  of  patients  enrolled  in  your  (HCH).
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1/ 7/ 13 Healthcare Home Medicat ion Management Survey
1/ 2https:/ / umpharm.qualt rics.com/ SE/ ?SID= SV_2mGgBqaCIkF29QU&Preview= Survey&BrandID= umpharm
0.5  FTE
1  FTE
1.5  FTE
2  FTE
Other
Urban
Rural
<  5
5-­10
11-­20
21-­30
31-­40
41-­50
>50
<  6  months
6  months  to  <  1  year
1  year  to  <  1.5  years
1.5  years  to  <  2  years
>/=  to  2  years
Background
  
My  clinic  has  ________  FTE  dedicated  to  care  coordination.  
My  clinic  is  located  in  a(n)  ____________  community.
Number  of  medical  providers  (physicians,  nurse  practitioners,  and  physician  assistants)  practicing  in  your
clinic.
How  long  has  your  clinic  been  a  certified  Health  Care  Home  (HCH)?
Estimate  the  number  of  patients  enrolled  in  your  (HCH).
1/ 7/ 13 Healthcare Home Medicat ion Management Survey
2/ 2https:/ / umpharm.qualt rics.com/ SE/ ?SID= SV_2mGgBqaCIkF29QU&Preview= Survey&BrandID= umpharm
<  20
20-­49
50-­99
100-­149
150-­199
>/=  200
Chiropractor(s)
Licensed  counselor(s)
Nurse  practitioner(s)
Occupational  therapist(s)
Pharmacist(s)
Physician  assistant(s)
Physical  therapist(s)
Primary  care  physician(s)
Psychiatrist(s)
Psychologist(s)
Registered  nurse(s)
Social  worker(s)
Others  (list)
Estimate  the  percentage  of  patients  are  enrolled  at  HCH  tier?  (Total  should  equal  100%.)  
0   I
0   II
0   III
0   IV
What  types  of  health  care  providers  are  on  your  team?  (Check  all  that  apply.)
  > >   
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1/ 7/ 13 Healthcare Home Medicat ion Management Survey
1/ 3https:/ / umpharm.qualt rics.com/ SE/ ?SID= SV_2mGgBqaCIkF29QU&Preview= Survey&BrandID= umpharm
<  or  =  10%
11-­20%
21-­30%
31-­40%
41-­50%
51-­60%
61-­70%
71-­80%
81-­90%
91-­100%
<  or  =  10%
11-­20%
21-­30%
31-­40%
41-­50%
51-­60%
61-­70%
71-­80%
81-­90%
91-­100%
<  or  =  10%
11-­20%
Care  coordination  dedicated  to  medication  use
  
Estimate  the  percentage  of  care  coordination  time  that  is  related  to  medication  adherence.    This  includes  the
time  you  spend  on  these  activities  as  well  as  the  time  you  spend  involving  other  providers  in  medication
adherence  related  activities.  Medication  adherence  is  defined  as  the  extent  to  which  patients  take  their
medications  as  prescribed.
Estimate  the  percentage  of  care  coordination  time  that  is  related  to  safety  of  medications  (e.g.  side  effects,
drug  interactions).    This  includes  the  time  you  spend  on  these  activities  as  well  as  the  time  you  spend  involving
other  providers  in  medication  safety  related  activities.
Estimate  the  percentage  of  care  coordination  time  dedicated  to  medication  monitoring  (e.g.  lab  values,  safety,
efficacy).    This  includes  the  time  you  spend  on  these  activities  as  well  as  the  time  you  spend  involving  other
providers  in  medication  monitoring  related  activities.
1/ 7/ 13 Healthcare Home Medicat ion Management Survey
2/ 3https:/ / umpharm.qualt rics.com/ SE/ ?SID= SV_2mGgBqaCIkF29QU&Preview= Survey&BrandID= umpharm
21-­30%
31-­40%
41-­50%
51-­60%
61-­70%
71-­80%
81-­90%
91-­100%
<  or  =  10%
11-­20%
21-­30%
31-­40%
41-­50%
51-­60%
61-­70%
71-­80%
81-­90%
91-­100%
Nurse  practitioner(s)
Pharmacist(s)
Physician(s)
Physician  Assistant(s)
Registered  Nurse(s)
Other  (list)
Not  sure
This  type  of  assessment  is  not  formally  provided  at  our  clinic
Estimate  the  percentage  of  care  coordination  time  that  is  spent  communicating  with  pharmacies  about
insurance  coverage,  access  to  medications,  prior  authorizations,  cost  and  issues  with  access.  This  includes
the  time  you  spend  on  these  activities  as  well  as  the  time  you  spend  involving  other  providers  in  medication
access  related  activities.
Comprehensive  medication  management  is  a  formal  assessment  that  determines  whether  a  patient’s
medications  (whether  they  are  prescription,  nonprescription,  alternative,  traditional,  vitamins,  or  nutritional
supplements)  is  appropriate  for  the  patient,  effective  for  the  medical  condition,  safe  given  the  medical
conditions  and  other  medications  being  taken,  and  able  to  be  taken  by  the  patient  as  intended.  In  your  clinic,
who  provides  comprehensive  medication  management  services?    (Check  all  that  apply.)
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1/ 7/ 13 Healthcare Home Medicat ion Management Survey
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21-­30%
31-­40%
41-­50%
51-­60%
61-­70%
71-­80%
81-­90%
91-­100%
<  or  =  10%
11-­20%
21-­30%
31-­40%
41-­50%
51-­60%
61-­70%
71-­80%
81-­90%
91-­100%
Nurse  practitioner(s)
Pharmacist(s)
Physician(s)
Physician  Assistant(s)
Registered  Nurse(s)
Other  (list)
Not  sure
This  type  of  assessment  is  not  formally  provided  at  our  clinic
Estimate  the  percentage  of  care  coordination  time  that  is  spent  communicating  with  pharmacies  about
insurance  coverage,  access  to  medications,  prior  authorizations,  cost  and  issues  with  access.  This  includes
the  time  you  spend  on  these  activities  as  well  as  the  time  you  spend  involving  other  providers  in  medication
access  related  activities.
Comprehensive  medication  management  is  a  formal  assessment  that  determines  whether  a  patient’s
medications  (whether  they  are  prescription,  nonprescription,  alternative,  traditional,  vitamins,  or  nutritional
supplements)  is  appropriate  for  the  patient,  effective  for  the  medical  condition,  safe  given  the  medical
conditions  and  other  medications  being  taken,  and  able  to  be  taken  by  the  patient  as  intended.  In  your  clinic,
who  provides  comprehensive  medication  management  services?    (Check  all  that  apply.)
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Yes
No
Pharmacist visits
Do you have a pharmacist on your HCH team?
  > >   
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1/ 7/ 13 Healthcare Home Medicat ion Management Survey
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Please rate your experience with the pharmacist on the healthcare home team.
     
Strongly
Agree Agree No Opinion Disagree
Strongly
Disagree Uncertain
Having a pharmacist on the
HCH team saves me time.
   
Having a pharmacist on the
HCH team is a great resource
for patients.
   
Having a pharmacist on the
HCH team is a great resource
for the care coordinator.
   
Having a pharmacist on the
HCH team is a great resource
for health care providers.
   
Having a pharmacist on the
team benefits the patient.
   
Having a pharmacist on the
team benefits the care
coordinator.
   
Having a pharmacist on the
team benefits medical staff.
   
  > >    
 
 
